{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:06:55Z","timestamp":1794917215654,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["14\/221\/02"],"award-info":[{"award-number":["14\/221\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sleep disturbance is common in dementia and often treated with Z-drugs (zopiclone, zaleplon, and zolpidem). While some observational studies suggest that Z-drugs are associated with adverse events such as falls and fracture risks in older people, this has not been studied in dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used data from 27,090 patients diagnosed with dementia between January 2000 and March 2016 from the Clinical Practice Research Datalink linked to Hospital Episodes Statistics data in England. We compared adverse events for 3532 patients newly prescribed Z-drugs by time-varying dosage to (1) 1833 non-sedative-users with sleep disturbance; (2) 10,214 non-sedative-users with proximal GP consultation matched on age, sex, and antipsychotic use; and (3) 5172 patients newly prescribed benzodiazepines. We defined higher dose Z-drugs and benzodiazepines as prescriptions equivalent to \u2265\u20097.5\u2009mg zopiclone or\u2009&gt;\u20095\u2009mg diazepam daily. Cox regression was used to estimate hazard ratios (HRs) for incident fracture, hip fracture, fall, mortality, acute bacterial infection, ischaemic stroke\/transient ischaemic attack, and venous thromboembolism over a 2-year follow-up, adjusted for demographic- and health-related covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean (SD) age of patients was 83 (7.7) years, and 16,802 (62%) were women. Of 3532 patients prescribed Z-drugs, 584 (17%) were initiated at higher doses. For patients prescribed higher dose Z-drugs relative to non-users with sleep disturbance, the HRs (95% confidence interval) for fractures, hip fractures, falls, and ischaemic stroke were 1.67 (1.13\u20132.46), 1.96 (1.16\u20133.31), 1.33 (1.06\u20131.66), and 1.88 (1.14\u20133.10), respectively. We observed similar associations when compared to non-sedative-users with proximal GP consultation. Minimal or inconsistent excess risks were observed at \u2264\u20093.75\u2009mg zopiclone or equivalent daily, and for mortality, infection, and venous thromboembolism. We observed no differences in adverse events for Z-drugs compared to benzodiazepines, except lower mortality rates with Z-drugs (HR [95% confidence interval] of 0.73 [0.64\u20130.83]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Higher dose Z-drug use in dementia is associated with increased fracture and stroke risks, similar or greater to that for higher dose benzodiazepines. Higher dose Z-drugs should be avoided, if possible, in people living with dementia, and non-pharmacological alternatives preferentially considered. Prescriptions for higher dose Z-drugs in dementia should be regularly reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ENCePP e-register of studies,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=18007\">EUPAS18006<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1186\/s12916-020-01821-5","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T02:03:38Z","timestamp":1606183418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-8413","authenticated-orcid":false,"given":"Kathryn","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon K.","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Maidment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Aldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Savva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"1821_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000335363","volume":"33","author":"B Guarnieri","year":"2012","unstructured":"Guarnieri B, Adorni F, Musicco M, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord. 2012;33:50\u20138. https:\/\/doi.org\/10.1159\/000335363.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jagp.2012.11.005","volume":"22","author":"LN Gitlin","year":"2014","unstructured":"Gitlin LN, Hodgson N, Piersol CV, et al. Correlates of quality of life for individuals with dementia living at home: the role of home environment, caregiver, and patient-related characteristics. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2014;22:587\u201397. https:\/\/doi.org\/10.1016\/j.jagp.2012.11.005.","journal-title":"Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry"},{"key":"1821_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/089198879901200203","volume":"12","author":"SM McCurry","year":"1999","unstructured":"McCurry SM, Logsdon RG, Teri L, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer\u2019s disease patients. J Geriatr Psychiatry Neurol. 1999;12:53\u20139. https:\/\/doi.org\/10.1177\/089198879901200203.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1821_CR4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089198879100400405","volume":"4","author":"CP Pollak","year":"1991","unstructured":"Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol. 1991;4:204\u201310.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1821_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00003495-199448010-00004","volume":"48","author":"H Ashton","year":"1994","unstructured":"Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994;48:25\u201340. https:\/\/doi.org\/10.2165\/00003495-199448010-00004.","journal-title":"Drugs"},{"key":"1821_CR6","first-page":"639","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29:639\u201358.","journal-title":"Drugs Aging"},{"key":"1821_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ageing\/13.6.335","volume":"13","author":"CG Swift","year":"1984","unstructured":"Swift CG, Swift MR, Hamley J, et al. Side-effect \u2018tolerance\u2019 in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing. 1984;13:335\u201343. https:\/\/doi.org\/10.1093\/ageing\/13.6.335.","journal-title":"Age Ageing"},{"key":"1821_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.18773\/austprescr.2015.055","volume":"38","author":"J Brett","year":"2015","unstructured":"Brett J, Murnion B. Management of benzodiazepine misuse and dependence. Aust Prescr. 2015;38:152\u20135. https:\/\/doi.org\/10.18773\/austprescr.2015.055.","journal-title":"Aust Prescr"},{"key":"1821_CR9","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952\u201360. https:\/\/doi.org\/10.1001\/archinternmed.2009.357.","journal-title":"Arch Intern Med"},{"key":"1821_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","volume":"9","author":"N Gunja","year":"2013","unstructured":"Gunja N. The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013;9:155\u201362. https:\/\/doi.org\/10.1007\/s13181-013-0292-0.","journal-title":"J Med Toxicol"},{"key":"1821_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169. https:\/\/doi.org\/10.1136\/bmj.38623.768588.47.","journal-title":"BMJ"},{"key":"1821_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afx167","volume":"47","author":"N Treves","year":"2018","unstructured":"Treves N, Perlman A, Kolenberg Geron L, et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing. 2018;47:201\u20138. https:\/\/doi.org\/10.1093\/ageing\/afx167.","journal-title":"Age Ageing"},{"key":"1821_CR13","doi-asserted-by":"publisher","first-page":"e0174730","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly K, Bracchi R, Hewitt J, et al. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. Plos One. 2017;12:e0174730. https:\/\/doi.org\/10.1371\/journal.pone.0174730.","journal-title":"Plos One"},{"key":"1821_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpsychires.2014.03.017","volume":"54","author":"C-Y Huang","year":"2014","unstructured":"Huang C-Y, Chou FH-C, Huang Y-S, et al. The association between zolpidem and infection in patients with sleep disturbance. J Psychiatr Res. 2014;54:116\u201320. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.03.017.","journal-title":"J Psychiatr Res"},{"key":"1821_CR15","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.4088\/JCP.12m08181","volume":"74","author":"W-S Huang","year":"2013","unstructured":"Huang W-S, Tsai C-H, Lin C-C, et al. Relationship between zolpidem use and stroke risk: a Taiwanese population\u2013based case-control study. J Clin Psychiatry. 2013;74:e433\u20138. https:\/\/doi.org\/10.4088\/JCP.12m08181.","journal-title":"J Clin Psychiatry"},{"key":"1821_CR16","doi-asserted-by":"publisher","unstructured":"Parsaik AK, Mascarenhas SS, Khosh-Chashm D, et al. Mortality associated with anxiolytic and hypnotic drugs\u2014a systematic review and meta-analysis. Aust N Z J Psychiatry. 2015:0004867415616695. https:\/\/doi.org\/10.1177\/0004867415616695.","DOI":"10.1177\/0004867415616695"},{"key":"1821_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1532-5415.2008.01711.x","volume":"56","author":"JL Givens","year":"2008","unstructured":"Givens JL, Sanft TB, Marcantonio ER. Functional recovery after hip fracture: the combined effects of depressive symptoms, cognitive impairment, and delirium. J Am Geriatr Soc. 2008;56:1075\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01711.x.","journal-title":"J Am Geriatr Soc"},{"key":"1821_CR18","doi-asserted-by":"publisher","unstructured":"McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev Published Online First: 2016. doi:https:\/\/doi.org\/10.1002\/14651858.CD009178.pub3.","DOI":"10.1002\/14651858.CD009178.pub3"},{"key":"1821_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2050-6511-14-56","volume":"14","author":"M Gustafsson","year":"2013","unstructured":"Gustafsson M, Karlsson S, Gustafson Y, et al. Psychotropic drug use among people with dementia \u2013 a six-month follow-up study. BMC Pharmacol Toxicol. 2013;14:56. https:\/\/doi.org\/10.1186\/2050-6511-14-56.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1821_CR20","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1001\/jama.295.24.2851","volume":"295","author":"B Sivertsen","year":"2006","unstructured":"Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295:2851\u20138. https:\/\/doi.org\/10.1001\/jama.295.24.2851.","journal-title":"JAMA"},{"key":"1821_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336. https:\/\/doi.org\/10.1093\/ije\/dyv098.","journal-title":"Int J Epidemiol"},{"key":"1821_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","volume":"300","author":"J Chisholm","year":"1990","unstructured":"Chisholm J. The Read clinical classification. Br Med J. 1990;300:1092. https:\/\/doi.org\/10.1136\/bmj.300.6732.1092.","journal-title":"Br Med J"},{"key":"1821_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/ije\/dyx015","volume":"46","author":"A Herbert","year":"2017","unstructured":"Herbert A, Wijlaars L, Zylbersztejn A, et al. Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC). Int J Epidemiol. 2017;46:1093\u20131093i. https:\/\/doi.org\/10.1093\/ije\/dyx015.","journal-title":"Int J Epidemiol"},{"key":"1821_CR24","volume-title":"Deaths registered in England and Wales: 2017","author":"V Patel","year":"2018","unstructured":"Patel V. Deaths registered in England and Wales: 2017. London: Office for National Statistics; 2018."},{"key":"1821_CR25","unstructured":"Department for Communities and Local Government, UK Government. English indices of deprivation 2015. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015. Accessed 22 Oct 2019."},{"key":"1821_CR26","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/ije\/dyw314","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA, Tilling K, Davey SG. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016;45:1866\u201386. https:\/\/doi.org\/10.1093\/ije\/dyw314.","journal-title":"Int J Epidemiol"},{"key":"1821_CR27","unstructured":"Rogers W. Regression standard errors in clustered samples. Stata Tech Bull 1994;3.https:\/\/econpapers.repec.org\/article\/tsjstbull\/y_3a1994_3av_3a3_3ai_3a13_3asg17.htm. Accessed 11 Dec 2019."},{"key":"1821_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515\u201326. https:\/\/doi.org\/10.1093\/biomet\/81.3.515.","journal-title":"Biometrika"},{"key":"1821_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1503\/cmaj.120592","volume":"185","author":"RHH Groenwold","year":"2013","unstructured":"Groenwold RHH, Klungel OH, Altman DG, et al. Adjustment for continuous confounders: an example of how to prevent residual confounding. CMAJ Can Med Assoc J. 2013;185:401\u20136. https:\/\/doi.org\/10.1503\/cmaj.120592.","journal-title":"CMAJ Can Med Assoc J"},{"key":"1821_CR30","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C De Laet","year":"2005","unstructured":"De Laet C, Kanis JA, Od\u00e9n A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330\u20138. https:\/\/doi.org\/10.1007\/s00198-005-1863-y.","journal-title":"Osteoporos Int"},{"key":"1821_CR31","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","volume":"319","author":"DG Altman","year":"1999","unstructured":"Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319:1492\u20135.","journal-title":"BMJ"},{"key":"1821_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377\u201399. https:\/\/doi.org\/10.1002\/sim.4067.","journal-title":"Stat Med"},{"key":"1821_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2307\/2346101","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289\u2013300. https:\/\/doi.org\/10.2307\/2346101.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"1821_CR34","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"1821_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jamda.2018.03.009","volume":"19","author":"S Sharma","year":"2018","unstructured":"Sharma S, Mueller C, Stewart R, et al. Predictors of falls and fractures leading to hospitalization in people with dementia: a representative cohort study. J Am Med Dir Assoc. 2018;19:607\u201312. https:\/\/doi.org\/10.1016\/j.jamda.2018.03.009.","journal-title":"J Am Med Dir Assoc"},{"key":"1821_CR36","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:e128\u201336. https:\/\/doi.org\/10.3399\/bjgp10X483562.","journal-title":"Br J Gen Pract"},{"key":"1821_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/pds.2630030106","volume":"3","author":"T-PV Staa","year":"1994","unstructured":"Staa T-PV, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf. 1994;3:15\u201321. https:\/\/doi.org\/10.1002\/pds.2630030106.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1821_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archinte.167.9.935","volume":"167","author":"C Huerta","year":"2007","unstructured":"Huerta C, Johansson S, Wallander M, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167:935\u201343. https:\/\/doi.org\/10.1001\/archinte.167.9.935.","journal-title":"Arch Intern Med"},{"key":"1821_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/pds.1919","volume":"19","author":"A Ruig\u00f3mez","year":"2010","unstructured":"Ruig\u00f3mez A, Mart\u00edn-Merino E, Rodr\u00edguez LAG. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf. 2010;19:579\u201385. https:\/\/doi.org\/10.1002\/pds.1919.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1821_CR40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/01.str.32.5.1085","volume":"32","author":"RG Gibbs","year":"2001","unstructured":"Gibbs RG, Newson R, Lawrenson R, et al. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke. 2001;32:1085\u201390. https:\/\/doi.org\/10.1161\/01.str.32.5.1085.","journal-title":"Stroke"},{"key":"1821_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1365-2125.1999.00928.x","volume":"47","author":"LE Derby","year":"1999","unstructured":"Derby LE, Myers MW, Jick H. Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. Br J Clin Pharmacol. 1999;47:565\u20139. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00928.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1821_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/qjmed\/hcp064","volume":"102","author":"J Gribbin","year":"2009","unstructured":"Gribbin J, Hubbard R, Smith C, et al. Incidence and mortality of falls amongst older people in primary care in the United Kingdom. QJM. 2009;102:477\u201383. https:\/\/doi.org\/10.1093\/qjmed\/hcp064.","journal-title":"QJM"},{"key":"1821_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158:915\u201320. https:\/\/doi.org\/10.1093\/aje\/kwg231.","journal-title":"Am J Epidemiol"},{"key":"1821_CR44","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1097\/MLR.0b013e318070c08e","volume":"45","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Patrick AR, St\u00fcrmer T, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45:S131\u201342. https:\/\/doi.org\/10.1097\/MLR.0b013e318070c08e.","journal-title":"Med Care"},{"key":"1821_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jamda.2017.09.015","volume":"19","author":"DD Dore","year":"2018","unstructured":"Dore DD, Zullo AR, Mor V, et al. Age, sex, and dose effects of nonbenzodiazepine hypnotics on hip fracture in nursing home residents. J Am Med Dir Assoc. 2018;19:328\u2013332.e2. https:\/\/doi.org\/10.1016\/j.jamda.2017.09.015.","journal-title":"J Am Med Dir Assoc"},{"key":"1821_CR46","doi-asserted-by":"publisher","first-page":"e0129366","DOI":"10.1371\/journal.pone.0129366","volume":"10","author":"H Tamiya","year":"2015","unstructured":"Tamiya H, Yasunaga H, Matusi H, et al. Hypnotics and the occurrence of bone fractures in hospitalized dementia patients: a matched case-control study using a national inpatient database. Plos One. 2015;10:e0129366. https:\/\/doi.org\/10.1371\/journal.pone.0129366.","journal-title":"Plos One"},{"key":"1821_CR47","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jamainternmed.2013.3795","volume":"173","author":"SD Berry","year":"2013","unstructured":"Berry SD, Lee Y, Cai S, et al. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med. 2013;173:754\u201361. https:\/\/doi.org\/10.1001\/jamainternmed.2013.3795.","journal-title":"JAMA Intern Med"},{"key":"1821_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12877-016-0383-2","volume":"16","author":"A-M Tolppanen","year":"2016","unstructured":"Tolppanen A-M, Taipale H, Tanskanen A, et al. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer\u2019s disease \u2013 exposure-matched cohort study. BMC Geriatr. 2016;16:204. https:\/\/doi.org\/10.1186\/s12877-016-0383-2.","journal-title":"BMC Geriatr"},{"key":"1821_CR49","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/j.1532-5415.2011.03591.x","volume":"59","author":"WD Finkle","year":"2011","unstructured":"Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc. 2011;59:1883\u201390. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03591.x.","journal-title":"J Am Geriatr Soc"},{"key":"1821_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs RD. 2017;17:493\u2013507. https:\/\/doi.org\/10.1007\/s40268-017-0207-7.","journal-title":"Drugs RD"},{"key":"1821_CR51","doi-asserted-by":"publisher","unstructured":"Frey DJ, Ortega JD, Wiseman C, et al. Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. J Am Geriatr Soc. 59:73\u201381. https:\/\/doi.org\/10.1111\/j.1532-5415.2010.03229.x.","DOI":"10.1111\/j.1532-5415.2010.03229.x"},{"key":"1821_CR52","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/00002512-200522090-00004","volume":"22","author":"H Allain","year":"2005","unstructured":"Allain H, Bentu\u00e9-Ferrer D, Polard E, et al. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005;22:749\u201365.","journal-title":"Drugs Aging"},{"key":"1821_CR53","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4172\/2167-7182.1000158","volume":"3","author":"SJ Diem","year":"2014","unstructured":"Diem SJ, Ewing SK, Stone KL, et al. Use of non-benzodiazepine sedative hypnotics and risk of falls in older men. J Gerontol Geriatr Res. 2014;3:158. https:\/\/doi.org\/10.4172\/2167-7182.1000158.","journal-title":"J Gerontol Geriatr Res"},{"key":"1821_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12877-017-0530-4","volume":"17","author":"N-W Yu","year":"2017","unstructured":"Yu N-W, Chen P-J, Tsai H-J, et al. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case\u2013control study in Taiwan. BMC Geriatr. 2017;17:140. https:\/\/doi.org\/10.1186\/s12877-017-0530-4.","journal-title":"BMC Geriatr"},{"key":"1821_CR55","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/0091270011405665","volume":"52","author":"CS Sterke","year":"2012","unstructured":"Sterke CS, van Beeck EF, van der Velde N, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52:947\u201355. https:\/\/doi.org\/10.1177\/0091270011405665.","journal-title":"J Clin Pharmacol"},{"key":"1821_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/YIC.0000000000000161","volume":"32","author":"H Taipale","year":"2017","unstructured":"Taipale H, Koponen M, Tanskanen A, et al. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer\u2019s disease. Int Clin Psychopharmacol. 2017;32:135\u201341. https:\/\/doi.org\/10.1097\/YIC.0000000000000161.","journal-title":"Int Clin Psychopharmacol"},{"key":"1821_CR57","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1212\/WNL.0000000000003037","volume":"87","author":"DM Hermann","year":"2016","unstructured":"Hermann DM, Bassetti CL. Role of sleep-disordered breathing and sleep-wake disturbances for stroke and stroke recovery. Neurology. 2016;87:1407\u201316. https:\/\/doi.org\/10.1212\/WNL.0000000000003037.","journal-title":"Neurology"},{"key":"1821_CR58","first-page":"377","volume":"5","author":"FL Joya","year":"2009","unstructured":"Joya FL, Kripke DF, Loving RT, et al. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2009;5:377\u201383.","journal-title":"J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med"},{"key":"1821_CR59","doi-asserted-by":"publisher","unstructured":"Nakafero G, Sanders RD, Nguyen-Van-Tam JS, et al. The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data. Pharmacoepidemiol Drug Saf 2016;:n\/a-n\/a. doi:https:\/\/doi.org\/10.1002\/pds.4028.","DOI":"10.1002\/pds.4028"},{"key":"1821_CR60","doi-asserted-by":"publisher","first-page":"e0179472","DOI":"10.1371\/journal.pone.0179472","volume":"12","author":"M-T Wang","year":"2017","unstructured":"Wang M-T, Wang Y-H, Chang H-A, et al. Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: a population-based nested case-control study. Plos One. 2017;12:e0179472. https:\/\/doi.org\/10.1371\/journal.pone.0179472.","journal-title":"Plos One"},{"key":"1821_CR61","doi-asserted-by":"publisher","first-page":"E519","DOI":"10.1503\/cmaj.160126","volume":"189","author":"H Taipale","year":"2017","unstructured":"Taipale H, Tolppanen A-M, Koponen M, et al. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease. CMAJ. 2017;189:E519\u201329. https:\/\/doi.org\/10.1503\/cmaj.160126.","journal-title":"CMAJ"},{"key":"1821_CR62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/gps.4821","volume":"33","author":"L Saarelainen","year":"2018","unstructured":"Saarelainen L, Tolppanen A-M, Koponen M, et al. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study. Int J Geriatr Psychiatry. 2018;33:583\u201390. https:\/\/doi.org\/10.1002\/gps.4821.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR63","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00228-015-1841-z","volume":"71","author":"CI Neutel","year":"2015","unstructured":"Neutel CI, Johansen HL. Association between hypnotics use and increased mortality: causation or confounding? Eur J Clin Pharmacol. 2015;71:637\u201342. https:\/\/doi.org\/10.1007\/s00228-015-1841-z.","journal-title":"Eur J Clin Pharmacol"},{"key":"1821_CR64","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/pgmj.71.838.466","volume":"71","author":"T Walley","year":"1995","unstructured":"Walley T, Scott AK. Prescribing in the elderly. Postgrad Med J. 1995;71:466\u201371.","journal-title":"Postgrad Med J"},{"key":"1821_CR65","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/bmj.39503.424653.80","volume":"336","author":"JC Milton","year":"2008","unstructured":"Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336:606\u20139. https:\/\/doi.org\/10.1136\/bmj.39503.424653.80.","journal-title":"BMJ"},{"key":"1821_CR66","doi-asserted-by":"publisher","unstructured":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019;67:674\u2013694. doi:https:\/\/doi.org\/10.1111\/jgs.15767.","DOI":"10.1111\/jgs.15767"},{"key":"1821_CR67","doi-asserted-by":"publisher","unstructured":"Brown EE, Kumar S, Rajji TK, et al. Anticipating and mitigating the impact of the COVID-19 pandemic on Alzheimer\u2019s disease and related dementias. Am J Geriatr Psychiatry Published Online First: 18 April 2020. doi:https:\/\/doi.org\/10.1016\/j.jagp.2020.04.010.","DOI":"10.1016\/j.jagp.2020.04.010"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01821-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:06:01Z","timestamp":1669723561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01821-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01821-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Independent Scientific Advisory Committee for CPRD for Clinical Practice Research Datalink research (protocol 16_181). No further ethical approval was required for the analysis of the data. The CPRD Group has obtained ethical approval from a multi-centre research ethics committee for all purely observational research using CPRD data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no support from any organisation for the submitted work beyond the NIHR grants listed above; YKL reports personal fees from Thame Pharmaceuticals outside of the submitted work, and CB reports grants and personal fees from Acadia pharmaceutical company and Lundbeck and personal fees from Roche, Otusaka, Novartis, Eli Lilly, and Pfizer; no other relationships or activities that could appear to have influenced the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}